CREDIT SUISSE NEW ISSUE: 10 American Call Warrants on Roche Holding Donnerstag, 15. Juni 2017 - 16:39
Dear Investor
Please find hereafter the details for these new issues:
Ticker | Valor | ISIN | Underlying | Spot | Strike | Ratio | Maturity | Type | Issue price | Impl. Vola | PDF File |
ROGKCS | 37 053 435 | CH 037 053 435 3 | Roche Holding AG | CHF 250.00 | CHF 220.00 | 50:1 | 21.06.2019 | Call | CHF 0.74 | 19.30% | |
ROGLCS | 37 053 436 | CH 037 053 436 1 | Roche Holding AG | CHF 250.00 | CHF 240.00 | 50:1 | 21.06.2019 | Call | CHF 0.50 | 18.50% | |
ROGMCS | 37 053 437 | CH 037 053 437 9 | Roche Holding AG | CHF 250.00 | CHF 260.00 | 50:1 | 21.06.2019 | Call | CHF 0.31 | 17.90% | |
ROGNCS | 37 053 438 | CH 037 053 438 7 | Roche Holding AG | CHF 250.00 | CHF 280.00 | 50:1 | 21.06.2019 | Call | CHF 0.19 | 17.50% | |
ROGOCS | 37 053 439 | CH 037 053 439 5 | Roche Holding AG | CHF 250.00 | CHF 300.00 | 50:1 | 21.06.2019 | Call | CHF 0.11 | 17.25% | |
ROGPCS | 37 053 440 | CH 037 053 440 3 | Roche Holding AG | CHF 250.00 | CHF 220.00 | 50:1 | 20.12.2019 | Call | CHF 0.78 | 19.50% | |
ROGQCS | 37 053 441 | CH 037 053 441 1 | Roche Holding AG | CHF 250.00 | CHF 240.00 | 50:1 | 20.12.2019 | Call | CHF 0.54 | 18.70% | |
ROGRCS | 37 053 442 | CH 037 053 442 9 | Roche Holding AG | CHF 250.00 | CHF 260.00 | 50:1 | 20.12.2019 | Call | CHF 0.36 | 18.00% | |
ROGSCS | 37 053 443 | CH 037 053 443 7 | Roche Holding AG | CHF 250.00 | CHF 280.00 | 50:1 | 20.12.2019 | Call | CHF 0.23 | 17.50% | |
ROGTCS | 37 053 444 | CH 037 053 444 5 | Roche Holding AG | CHF 250.00 | CHF 300.00 | 50:1 | 20.12.2019 | Call | CHF 0.15 | 17.25% |
Please visit our website http://www.credit-suisse.com/derivatives to see the complete list of our products.
The warrants will be placed directly in the secondary market. Please call 044/335 76 00.
Kind regards
CREDIT SUISSE AG
Investment Banking
Equity Derivatives & Structured Products
Uetlibergstrasse 231
8070 Zürich, Switzerland
Tel: +41 44 - 335 76 00
Fax: +41 44 - 333 78 08
www.credit-suisse.com
This message may contain confidential, proprietary or legally privileged information and is intended only for the use of the addressee named above. No confidentiality or privilege is waived or lost by any mistransmission. If you are not the intended recipient of this message you are hereby notified that you must not use, disseminate, copy it in any form or take any action in reliance on it. If you have received this message in error please delete it and any copies of it and notify the sender immediately. Credit Suisse Group and its subsidiaries reserve the right to intercept and monitor any e-mail communication through its networks if legally allowed.